These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 11079361)

  • 1. Axial penile rigidity as primary efficacy outcome during multi-institutional in-office dose titration clinical trials with alprostadil alfadex in patients with erectile dysfunction. Alprostadil Alfadex Study Group.
    Goldstein I; Auerbach S; Padma-Nathan H; Rajfer J; Fitch W; Schmitt L
    Int J Impot Res; 2000 Aug; 12(4):205-11. PubMed ID: 11079361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction.
    Buvat J; Costa P; Morlier D; Lecocq B; Stegmann B; Albrecht D
    J Urol; 1998 Jan; 159(1):116-9. PubMed ID: 9400450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra).
    Shabsigh R; Padma-Nathan H; Gittleman M; McMurray J; Kaufman J; Goldstein I
    Urology; 2000 Apr; 55(4):477-80. PubMed ID: 10736486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study.
    Shabsigh R; Padma-Nathan H; Gittleman M; McMurray J; Kaufman J; Goldstein I
    Urology; 2000 Jan; 55(1):109-13. PubMed ID: 10654905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernous Alprostadil Alfadex--an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study.
    Porst H; Buvat J; Meuleman E; Michal V; Wagner G
    Int J Impot Res; 1998 Dec; 10(4):225-31. PubMed ID: 9884918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal hemodynamic parameters do not always predict the presence of a rigid erection: a quantitative assessment of functional erectile impairment.
    Hatzichristou DG; Hatzimouratidis K; Tzortzis V; Apostolidis A; Bekos A; Ioannidis E
    Int J Impot Res; 2003 Apr; 15(2):99-104. PubMed ID: 12789388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
    Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of pharmacologically-induced penile erections: the value of radionuclide phallography in the objective evaluation of erectile haemodynamics.
    Siraj QH; Bomanji J; Akhtar MA; Rana MH; Sadiq M; Ahmed M
    Nucl Med Commun; 1990 Jun; 11(6):445-58. PubMed ID: 2385430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury.
    Bodner DR; Haas CA; Krueger B; Seftel AD
    Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intraurethral liposomal and intracavernosal prostaglandin-E1 in the management of erectile dysfunction.
    Engelhardt PF; Plas E; Hübner WA; Pflüger H
    Br J Urol; 1998 Mar; 81(3):441-4. PubMed ID: 9523667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axial penile buckling forces vs Rigiscan radial rigidity as a function of intracavernosal pressure: why Rigiscan does not predict functional erections in individual patients.
    Udelson D; Park K; Sadeghi-Nejad H; Salimpour P; Krane RJ; Goldstein I
    Int J Impot Res; 1999 Dec; 11(6):327-37; discusion 337-9. PubMed ID: 10637463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Titration study of MUSE (Medicated Urethral System for Erection) in erectile dysfunction.
    Chiang HS; Wen TC; Liang JF
    J Formos Med Assoc; 2000 Dec; 99(12):926-30. PubMed ID: 11155746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response study of alprostadil sterile powder (S.Po.) (Caverject) for the treatment of erectile dysfunction in Korean and Indonesian men.
    Choi HK; Adimoelja A; Kim SC; Soebadi DM; Seong DH; Garceau RJ
    Int J Impot Res; 1997 Mar; 9(1):47-51. PubMed ID: 9138059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of alprostadil sterile powder (S. Po., CAVERJECT) in diabetic patients with erectile dysfunction.
    Tsai YS; Lin JS; Lin YM
    Eur Urol; 2000 Aug; 38(2):177-83. PubMed ID: 10895010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The therapeutic and diagnostic potentials of the intra-corpora cavernosa use of alprostadil, Edex, in patients with erectile dysfunction].
    Mzo EB; Dmitriev DG
    Ter Arkh; 1995; 67(10):45-8. PubMed ID: 8779105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment.
    Brock G; Tu LM; Linet OI
    Urology; 2001 Mar; 57(3):536-41. PubMed ID: 11248634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The patient's self-evaluation better predicts the degree of erectile dysfunction than the response to intracavernous alprostadil testing.
    Casella R; Deckart A; Bachmann A; Sulser T; Gasser TC; Lehmann K
    Urol Int; 2004; 72(3):216-20. PubMed ID: 15084765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.